In this cohort study, the quadrivalent human papillomavirus (HPV) vaccine provides strong, long-lasting protection against ...

The anticipated licensure within the next three months of a vaccine against human papillomavirus (HPV) would represent a major public health advance against cervical cancer and other, less common ...

Patients with thyroid eye disease (TED) have a higher prevalence of low-risk human papillomavirus (HPV) diagnosed before ...

Sierra Leone surpasses Human Papillomavirus (HPV) vaccination campaign targets, closes gap on cervical cancer elimination ...

Human papillomavirus (HPV) is now established as the principal cause of an increase in incidence of a subset of head and neck squamous cell cancers (HNCs) in numerous geographic regions around the ...

Papillomas are noncancerous growths that can develop on your skin or mucous membranes. They rarely turn cancerous but can cause problems if they grow large and press on healthy tissue. Infection with ...

We integrated data from multiple analytes (HPV DNA, HPV RNA, and p16), assays (immunohistochemistry, polymerase chain reaction [PCR], quantitative PCR [qPCR], and digital PCR), and molecular changes ...

Developed in 2018 by the International Papillomavirus Society (IPVS), International HPV Awareness Day is marked annually now on March 4 and is an annual opportunity to educate about Human ...